Glaukos is seeking to position the implant as a way to spare patients from the need to take twice-daily eye drops. (Pixabay) Glaukos’ intraocular implant has performed comparably to topical…

Amneal Pharmaceuticals has struck a deal to buy a 98% stake in Kashiv Specialty Pharmaceuticals for $70 million upfront. The takeover will give Amneal control of drug delivery platforms and…

That didn’t take long. Fujifilm is laying plans for a new manufacturing facility in Watertown, Massachusetts—the second it’s announced in a little over a week. Fujifilm and The Massachusetts Center…

Novartis plunked down up to $2.2 billion for BeiGene’s China-approved PD-1 drug tislelizumab to complement its own checkpoint inhibitor. Hear what BeiGene CEO John Oyler has to say about tislelizumab’s…

We hear you guys loud and clear: You’re pretty sure J.P. Morgan’s days in San Francisco are done, and you basically couldn’t be happier about it. That’s the message, at…

President-elect Joe Biden has chosen former FDA chief David Kessler to lead the COVID-19 vaccine scale-up.(Photo by AndrewSoundarajan/iStock/Getty Images Plus/Getty Images) With Moncef Slaoui’s final days as a co-leader of…

COVID-19 lockdowns last year brought challenges for companies in nearly every industry—including pharmaceutical companies trying to get the word out about new drugs. But for companies with established connections, technology…